Imprimis Pharmaceuticals Inc., of San Diego, has changed its name to Harrow Health Inc. and will now trade on Nasdaq under the symbol HROW. The company will continue to operate its ophthalmology-focused compounding business as a subsidiary under the name Imprimisrx.